Titre : Tumeurs de la trachée

Tumeurs de la trachée : Questions médicales fréquentes

Termes MeSH sélectionnés :

Observational Studies as Topic
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tumeurs de la trachée : Questions médicales les plus fréquentes", "headline": "Tumeurs de la trachée : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tumeurs de la trachée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-15", "dateModified": "2025-04-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tumeurs de la trachée" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladie de la trachée", "url": "https://questionsmedicales.fr/mesh/D014133", "about": { "@type": "MedicalCondition", "name": "Maladie de la trachée", "code": { "@type": "MedicalCode", "code": "D014133", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C08.907" } } }, "about": { "@type": "MedicalCondition", "name": "Tumeurs de la trachée", "alternateName": "Tracheal Neoplasms", "code": { "@type": "MedicalCode", "code": "D014134", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "V D Parshin", "url": "https://questionsmedicales.fr/author/V%20D%20Parshin", "affiliation": { "@type": "Organization", "name": "Sechenov First Moscow State Medical University, Moscow, Russia." } }, { "@type": "Person", "name": "M A Rusakov", "url": "https://questionsmedicales.fr/author/M%20A%20Rusakov", "affiliation": { "@type": "Organization", "name": "Sechenov First Moscow State Medical University, Moscow, Russia." } }, { "@type": "Person", "name": "M S Simonova", "url": "https://questionsmedicales.fr/author/M%20S%20Simonova", "affiliation": { "@type": "Organization", "name": "Sechenov First Moscow State Medical University, Moscow, Russia." } }, { "@type": "Person", "name": "M A Ursov", "url": "https://questionsmedicales.fr/author/M%20A%20Ursov", "affiliation": { "@type": "Organization", "name": "Sechenov First Moscow State Medical University, Moscow, Russia." } }, { "@type": "Person", "name": "Keiichi Morita", "url": "https://questionsmedicales.fr/author/Keiichi%20Morita", "affiliation": { "@type": "Organization", "name": "Department of Pediatric Surgery, Kobe Children's Hospital, 1-6-7, Minatojima Minami-cho, Chuo-ku, Kobe, 650-0047, Japan." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Postdischarge nausea and vomiting (PDNV) in children: A review and observational study.", "datePublished": "2023-05-18", "url": "https://questionsmedicales.fr/article/37222143", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.5507/bp.2023.020" } }, { "@type": "ScholarlyArticle", "name": "Plerixafor use in New Zealand 2016-2019: an observational study.", "datePublished": "2022-09-06", "url": "https://questionsmedicales.fr/article/35560504", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/imj.15819" } }, { "@type": "ScholarlyArticle", "name": "Protocol for an observational study investigating hormones triggering the onset of sustained lactation: the INSIGHT study.", "datePublished": "2022-08-30", "url": "https://questionsmedicales.fr/article/36041762", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2022-062478" } }, { "@type": "ScholarlyArticle", "name": "Risk factors for gastric cancer: A comprehensive analysis of observational studies.", "datePublished": "2023-01-04", "url": "https://questionsmedicales.fr/article/36684855", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2022.892468" } }, { "@type": "ScholarlyArticle", "name": "Prevalence of Multimorbidity in the Middle East: A Systematic Review of Observational Studies.", "datePublished": "2022-12-08", "url": "https://questionsmedicales.fr/article/36554382", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph192416502" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies de l'appareil respiratoire", "item": "https://questionsmedicales.fr/mesh/D012140" }, { "@type": "ListItem", "position": 3, "name": "Maladie de la trachée", "item": "https://questionsmedicales.fr/mesh/D014133" }, { "@type": "ListItem", "position": 4, "name": "Tumeurs de la trachée", "item": "https://questionsmedicales.fr/mesh/D014134" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tumeurs de la trachée - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tumeurs de la trachée", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tumeurs de la trachée", "description": "Comment diagnostique-t-on une tumeur de la trachée ?\nQuels tests sont utilisés pour évaluer la fonction respiratoire ?\nLes examens d'imagerie sont-ils toujours nécessaires ?\nQuels symptômes peuvent indiquer une tumeur trachéale ?\nLa biopsie est-elle toujours requise pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Observational+Studies+as+Topic&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tumeurs de la trachée", "description": "Quels sont les symptômes courants des tumeurs trachéales ?\nLa voix peut-elle être affectée par une tumeur trachéale ?\nLes symptômes varient-ils selon le type de tumeur ?\nPeut-on avoir des symptômes sans tumeur visible ?\nLes symptômes peuvent-ils s'aggraver rapidement ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Observational+Studies+as+Topic&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tumeurs de la trachée", "description": "Peut-on prévenir les tumeurs de la trachée ?\nLe tabagisme est-il un facteur de risque ?\nLes expositions professionnelles peuvent-elles être un risque ?\nY a-t-il des vaccins pour prévenir ces tumeurs ?\nUne alimentation saine peut-elle aider à prévenir ces tumeurs ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Observational+Studies+as+Topic&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tumeurs de la trachée", "description": "Quels traitements sont disponibles pour les tumeurs trachéales ?\nLa chirurgie est-elle toujours nécessaire ?\nLa radiothérapie est-elle efficace contre ces tumeurs ?\nQuels sont les effets secondaires des traitements ?\nPeut-on combiner plusieurs traitements ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Observational+Studies+as+Topic&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tumeurs de la trachée", "description": "Quelles complications peuvent survenir avec ces tumeurs ?\nLes tumeurs trachéales peuvent-elles se propager ?\nComment les complications affectent-elles le traitement ?\nLes infections sont-elles fréquentes avec ces tumeurs ?\nPeut-on prévenir les complications ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Observational+Studies+as+Topic&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tumeurs de la trachée", "description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque de tumeurs trachéales ?\nLes antécédents médicaux jouent-ils un rôle ?\nLes infections respiratoires chroniques sont-elles un facteur de risque ?\nLes facteurs environnementaux influencent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D014134?mesh_terms=Observational+Studies+as+Topic&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une tumeur de la trachée ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par imagerie (CT, IRM) et bronchoscopie pour biopsie." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la fonction respiratoire ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de fonction pulmonaire mesurent la capacité respiratoire et l'obstruction." } }, { "@type": "Question", "name": "Les examens d'imagerie sont-ils toujours nécessaires ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont essentiels pour visualiser la tumeur et son extension." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une tumeur trachéale ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Toux persistante, difficultés respiratoires, et stridor peuvent alerter." } }, { "@type": "Question", "name": "La biopsie est-elle toujours requise pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la biopsie confirme la nature bénigne ou maligne de la tumeur." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des tumeurs trachéales ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Toux, dyspnée, stridor, douleur thoracique et hémoptysie sont fréquents." } }, { "@type": "Question", "name": "La voix peut-elle être affectée par une tumeur trachéale ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une tumeur peut provoquer des changements de voix ou une dysphonie." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de tumeur ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent différer entre tumeurs bénignes et malignes." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes sans tumeur visible ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes peuvent apparaître même si la tumeur est petite ou cachée." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils s'aggraver rapidement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines tumeurs peuvent croître rapidement et aggraver les symptômes." } }, { "@type": "Question", "name": "Peut-on prévenir les tumeurs de la trachée ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de méthode de prévention spécifique, mais éviter le tabac aide." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme augmente le risque de développer des tumeurs respiratoires." } }, { "@type": "Question", "name": "Les expositions professionnelles peuvent-elles être un risque ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des substances toxiques peut augmenter le risque de tumeurs." } }, { "@type": "Question", "name": "Y a-t-il des vaccins pour prévenir ces tumeurs ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Non, il n'existe pas de vaccins spécifiques pour prévenir les tumeurs trachéales." } }, { "@type": "Question", "name": "Une alimentation saine peut-elle aider à prévenir ces tumeurs ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut réduire le risque de cancer en général." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les tumeurs trachéales ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les options incluent la chirurgie, la radiothérapie et la chimiothérapie." } }, { "@type": "Question", "name": "La chirurgie est-elle toujours nécessaire ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, cela dépend de la taille et de la localisation de la tumeur." } }, { "@type": "Question", "name": "La radiothérapie est-elle efficace contre ces tumeurs ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut être utilisée pour réduire la taille des tumeurs malignes." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets peuvent inclure fatigue, irritation des voies respiratoires et nausées." } }, { "@type": "Question", "name": "Peut-on combiner plusieurs traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une approche multimodale est souvent utilisée pour optimiser les résultats." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec ces tumeurs ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent obstruction des voies respiratoires et infections." } }, { "@type": "Question", "name": "Les tumeurs trachéales peuvent-elles se propager ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent envahir les tissus voisins ou se propager à d'autres organes." } }, { "@type": "Question", "name": "Comment les complications affectent-elles le traitement ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent compliquer le traitement et nécessiter des interventions supplémentaires." } }, { "@type": "Question", "name": "Les infections sont-elles fréquentes avec ces tumeurs ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections respiratoires peuvent survenir en raison de l'obstruction." } }, { "@type": "Question", "name": "Peut-on prévenir les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par un suivi médical régulier." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'exposition à des produits chimiques et des antécédents familiaux." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de tumeurs trachéales ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque augmente avec l'âge, surtout après 50 ans." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de cancer ou de maladies respiratoires augmentent le risque." } }, { "@type": "Question", "name": "Les infections respiratoires chroniques sont-elles un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent prédisposer à des tumeurs trachéales." } }, { "@type": "Question", "name": "Les facteurs environnementaux influencent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la pollution de l'air et l'exposition à des irritants augmentent le risque." } } ] } ] }

Sources (10000 au total)

Plerixafor use in New Zealand 2016-2019: an observational study.

Plerixafor is used to mobilise CD34-positive stem cells for autologous transplantation to treat haematological malignancy. Funded in New Zealand since 2016, plerixafor can be used 'pre-emptively' to s... To establish success rates for conditioning regimes used in New Zealand.... We reviewed 203 consecutive patients with myeloma (n = 122) or lymphoma (n = 81) undergoing stem cell mobilisation between 1 January 2016 and 5 August 2019 at Christchurch hospital. We recorded demogr... Seventeen percent of patients received plerixafor. Harvest success rates for lymphoma and myeloma respectively were 77% and 86% with standard conditioning, 95% and 100% with 'pre-emptive' plerixafor a... Plerixafor strategies in New Zealand allow successful stem cell mobilisation for ≥96% of patients. Further research is required to investigate whether increased use would be cost-effective through red...

Protocol for an observational study investigating hormones triggering the onset of sustained lactation: the INSIGHT study.

Lactation is a hormonally controlled process that promotes infant growth and neurodevelopment and reduces the long-term maternal risk of diabetes, cardiovascular disease and breast cancer. Hormones, s... The primary objective of the investigating hormones triggering the onset of sustained lactation study is to establish reference intervals for the circulating hormone concentrations initiating postpart... Approval for this study had been granted by the East of England-Cambridgeshire and Hertfordshire Research Ethics Committee (REC No. 20/EE/0172), by the Health Research Authority (HRA), and by the Oxfo... ISRCTN12667795....

Risk factors for gastric cancer: A comprehensive analysis of observational studies.

Multifarious factors have a causal relationship with gastric cancer (GC) development. We conducted a comprehensive analysis to evaluate the strength of the evidence examining non-genetic risk factors ... PubMed, Web of Science, and the Cochrane Library were searched from inception to November 10, 2021 to identify meta-analyses of observational studies examining the association between environmental fa... A total of 137 associations were examined in 76 articles. Among these meta-analyses, 93 associations yielded significant estimates (... In this comprehensive analysis, multiple associations were found between environmental factors and GC with varying levels of evidence. Healthy dietary habits and lifestyle patterns could reduce the ri...

Prevalence of Multimorbidity in the Middle East: A Systematic Review of Observational Studies.

There has not been a review that evaluated the prevalence of multimorbidity in the Middle East. This review aims to measure the prevalence, demographic factors, and consequences of multimorbidity in t... A quantitative systematic review includes cross-sectional and longitudinal cohort studies.... The prevalence systematic review approach from the Joanna Briggs Institute was applied. We searched PsychINFO, MEDLINE, EMCARE, CINAHL, Scopus, Science Direct, and the Cochrane Central Register of Con... The final sample consisted of eight cohort and observational studies. The number of participants varied from 354 to 796,427. Multimorbidity was present in all populations with a prevalence of 21.8% (9... Multimorbidity affects a significant section of the world's population. A uniform operationalization of multimorbidity is required in the Middle East in order to enable reliable estimates of illness b...

Study Protocol of a Prospective Multicenter Observational Study Evaluating Acute Lower Limb Ischemia.

Acute lower limb ischemia (ALI) is a limb- and potentially life-threatening condition which requires urgent evaluation and treatment. Contemporary data on optimal therapy and prognosis of ALI are lack... The proposed study is a prospective, international, multicenter, observational study on ALI (PROMOTE-ALI) (ClinicalTrials.gov - NCT05138679). Patients with ALI (Rutherford classification grade I -III)... ALI remains a challenging condition and due to the heterogeneous etiology, clinical presentation and treatment strategies, a large multicenter study on this topic is needed to gain contemporary data o...

Improving the care of children with GENetic Rare disease: Observational Cohort study (GenROC)-a study protocol.

Around 2000 children are born in the UK per year with a neurodevelopmental genetic syndrome with significantly increased morbidity and mortality. Often little is known about expected growth and phenot... This is an observational, multicentre cohort study recruiting between March 2023 and February 2026. Children aged 6 months up to 16 years with a pathogenic or likely pathogenic variant in a specified ... The results will be presented at national and international conferences concerning the care of children with genetic syndromes. Results will also be submitted for peer review and publication....